The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of sonidegib in patients (pts) with locally advanced (la) or metastatic (m) basal cell carcinoma (BCC): BOLT 30-month analysis.
 
Reinhard Dummer
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
 
Michael Robert Migden
Honoraria - Genentech; Lilly; Novartis
Consulting or Advisory Role - Genentech; Lilly; Novartis
Research Funding - Genentech (Inst)
Travel, Accommodations, Expenses - Genentech; Lilly; Novartis
 
Alexander Guminski
Consulting or Advisory Role - Bristol-Myers Squibb; Pfizer
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Merck; Novartis; Pfizer
 
Ralf Gutzmer
Honoraria - Almirall Hermal GmbH; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Merck Serono; MSD; Novartis; Roche
Consulting or Advisory Role - Almirall Hermal GmbH; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; LEO Pharma; MSD; Novartis; Pfizer; Roche
Research Funding - Johnson & Johnson (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Ragini Reiney Kudchadkar
Honoraria - Bristol-Myers Squibb; Genentech
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech
 
Karl D. Lewis
Research Funding - Novartis (Inst)
 
Luc Dirix
No Relationships to Disclose
 
Patrick Combemale
No Relationships to Disclose
 
Uwe Trefzer
Honoraria - Merck; Novartis; Roche
Consulting or Advisory Role - Merck; Roche
Speakers' Bureau - Novartis
 
Carmen Loquai
Honoraria - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Roche
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
 
Martin Kaatz
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
Research Funding - Federal Ministry of Education and Research
Expert Testimony - Novartis; Roche
 
Anne L. S. Chang
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Research Funding - Novartis (Inst)
 
Alexander Stratigos
No Relationships to Disclose
 
Elizabeth R. Plummer
Honoraria - Bristol-Myers Squibb; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Biomarin; Clovis Oncology; Karus Therapeutics; Mission Therapeutics; MSD Oncology; Novartis; Roche/Genentech; Tesaro; Vertex
Speakers' Bureau - Novartis
Research Funding - AstraZeneca/MedImmune (Inst); Clovis Oncology (Inst); Eisai (Inst); Etherapeutics (Inst); Ipsen (Inst); vertex (Inst)
Patents, Royalties, Other Intellectual Property - Named on patent of use of PARP inhibitor rucaparib (Inst)
Travel, Accommodations, Expenses - MSD Oncology; Roche/Genentech
 
Manisha Mone
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Henry J. Castro
Employment - Novartis
 
Tingting Yi
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Dalila B. Sellami
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
John Lear
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - Novartis